e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Newborn cystic fibrosis screening: influence of prematurity on the concentration of immunoreactive trypsinogen [IRT]
M. Montgomery, M. Stephenson, V. Lim, S. Menon, C. Larsen, H. Wilde, P. Bridge, M. Lyon (Calgary, AB, Canada)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
339
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Montgomery, M. Stephenson, V. Lim, S. Menon, C. Larsen, H. Wilde, P. Bridge, M. Lyon (Calgary, AB, Canada). Newborn cystic fibrosis screening: influence of prematurity on the concentration of immunoreactive trypsinogen [IRT]. Eur Respir J 2007; 30: Suppl. 51, 339
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Newborn cystic fibrosis (CF) screening: influence of data transformation and density estimation on newborn recall
Source: Eur Respir J 2007; 30: Suppl. 51, 30s
Year: 2007
Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Infant pulmonary function - Raised Volume Technique
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Stenotrophomonas maltophilia
and
achromobacter xylosoxidans
in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Impact of sensitization to
Aspergillus fumigatus
on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Underestimation of lung clearance index values in infants with cystic fibrosis due to software analysis algorithms
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015
Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Audit of management of
pseudomonas aeruginosa
infection in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF)
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Should the D1152H variant be included in cystic fibrosis newborn screening programmes?
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Newborn screening for cystic fibrosis in Spain
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept